Therapeutic potential of phages in autoimmune liver diseases
Open Access
- 20 December 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 192 (1) , 1-6
Abstract
Summary: Autoimmune liver disease (ALD) poses a difficult medical challenge, as there is a significant number of patients in whom current therapy offers questionable or no benefit, yet its side effects may be serious, including the development of malignancy. Bacterial viruses (phages) have been recognized increasingly as immunomodulators contributing to immune homeostasis and curbing inflammation. Accumulating data suggest that phages may be useful in immunotherapy of ALD. Phages have been shown to down-regulate the expression and/or production and activity of factors associated with hepatic injury [reactive oxygen species, Toll-like receptor (TLR)-4 activation, nuclear factor kappa B (NF-κB) activation, proinflammatory and procoagulant activities of platelets] and up-regulate the expression and/or production of factors demonstrated as playing a protective role [interleukin (IL)-10, IL-1 receptor antagonist].Keywords
Funding Information
- National Science Center (DEC-2013/11/B/NZ1/02107)
- Wroclaw Centre of Biotechnology
- Krajowy Naukowy Osrodek Wiodacy
This publication has 65 references indexed in Scilit:
- Bacteriophage adhering to mucus provide a non–host-derived immunityProceedings of the National Academy of Sciences, 2013
- Treatment of autoimmune liver disease: current and future therapeutic optionsTherapeutic Advances in Chronic Disease, 2013
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis BProceedings of the National Academy of Sciences, 2012
- Experimental Phage Therapy in TreatingKlebsiella pneumoniae-Mediated Liver Abscesses and Bacteremia in MiceAntimicrobial Agents and Chemotherapy, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseasesHepatology International, 2010
- Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-βHepatology, 2010
- Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver†Hepatology, 2009
- Bacterial viruses against viruses pathogenic for man?Virus Research, 2005
- The potential role of endogenous bacteriophages in controlling invading pathogensCellular and Molecular Life Sciences, 2005